. Faculdade de Ciências da Saúde, Universidade da Beira Interior, Covilhã, Portugal.
. Liverpool Heart and Chest Hospital NHS Foundation Trust, Liverpool, United Kingdom.
J Bras Pneumol. 2022 Feb 2;48(1):e20210371. doi: 10.36416/1806-3756/e20210371. eCollection 2022.
Lung cancer screening (LCS) programs are increasing worldwide. Incidental findings (IFs) on LCS are defined as low-dose CT findings unrelated to the primary purpose of identifying lung cancer. Most IFs on LCS are benign and clinically insignificant but are being increasingly recognized, and some require urgent referral for further diagnostic workup. Other findings are expected and are known as smoking-related comorbidities, including COPD, cardiovascular disease, emphysema, and interstitial lung disease, and their diagnosis can have a significant impact on patient prognosis. The purpose of this pictorial essay is to illustrate the most common IFs on LCS, organized by organ. We will discuss the current literature on IFs on LCS, focusing on their prevalence, appropriate communication, and triggering of clinical pathway systems.
肺癌筛查（LCS）项目在全球范围内不断增加。LCS 中的偶然发现（IFs）被定义为与识别肺癌的主要目的无关的低剂量 CT 发现。LCS 中的大多数 IFs 是良性的且无临床意义，但越来越受到重视，有些则需要紧急转介进行进一步的诊断检查。其他发现是预期的，被称为与吸烟相关的合并症，包括 COPD、心血管疾病、肺气肿和间质性肺病，其诊断对患者预后有重大影响。本文图稿的目的是通过器官分类来展示 LCS 中最常见的 IFs。我们将讨论 LCS 中 IFs 的当前文献，重点关注其患病率、适当的沟通以及触发临床路径系统。
